Medindia

X

Rosetta Genomics Announces Issuance of Additional U.S. Patent

Wednesday, May 11, 2011 General News J E 4
Advertisement
Strengthens its Broad and Deep microRNA Intellectual Property for microRNA-based Diagnostics

Company Contact:

Investor Contacts:

Rosetta Genomics

Lippert/Heilshorn & Associates

Ken Berlin, President & CEO

Anne Marie Fields

(215) 382-9000 ext. 326

(212) 838-3777

investors@rosettagenomics.com

afields@lhai.com

or

Bruce Voss

(310) 691-7100

bvoss@lhai.com

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
TriReme Medical Lines Up Asian Strategy With Key A...
S
Advanced Cell Technology Announces 2011 First Quar...